| Financial Year |
March 31 2023 |
| Monetary Funds |
180,792,350.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
632,703,424.33 |
| Advances to Suppliers |
112,334,382.62 |
| Other Receivables |
21,853,964.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
771,813,920.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,752,713.36 |
| Total Current Assets |
1,767,990,229.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
62,598,718.38 |
| Investment Properties |
-- |
| Fixed Assetes |
92,546,335.77 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,752,803.85 |
| R&D expenses |
24,811,153.25 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,714,266.28 |
| Deferred Income Tax Assets |
9,114,156.78 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
250,028,526.22 |
| Total Assets |
2,018,018,756.06 |
| Short-Term Loans |
256,353,240.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
84,862,059.68 |
| Accounts Payable |
184,177,052.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
38,547,547.78 |
| Taxes Payable |
25,210,108.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,368,741.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,341,277.29 |
| Other Current Liabilities |
3,002,864.41 |
| Sub-Total of Current Liabilities |
733,633,017.46 |
| Long-term Loans |
12,162,162.13 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,464,354.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,020,065.89 |
| Total Liabilities |
751,653,083.35 |
| Paid-In Capital(Or Share Stock) |
308,429,398.00 |
| Capital Surplus |
251,379,519.08 |
| Surplus Reserve |
72,777,391.89 |
| LESS:Treasury Stock |
1,520,652.00 |
| Undistributed Profits |
635,300,015.74 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,266,365,672.71 |
| Owner's Equity（Stockholder's Equity） |
1,266,365,672.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,018,018,756.06 |
